Who we are
Headquartered in Espoo, Finland, Mobidiag is a biotechnology company specializing in developing and marketing novel, innovative solutions for molecular diagnostics of infectious diseases. Mobidiag has a subsidiary in Paris, France.
Mobidiag develops cutting-edge diagnostic platforms and test kits. Our mission is to address the unmet need for high information-density, affordable molecular diagnostic tools to enable the rapid treatment and triage of patients at the point of impact.
Mobidiag’s Amplidiag product line encompasses multiplex diagnostic tests for gastrointestinal infections. The products utilize well-established multiplex real-time PCR technology for optimal performance, suitability to high-volume screening use and cost-effectiveness in large laboratory settings. Amplidiag Easy makes your stool testing workflow fast and easy – from primary sample to final result. All products come with Amplidiag Analyzer – an intuitive software for automated result analysis and reporting.
The entirely new Novodiag platform is a fully integrated and automated system, which enables fast, easy to use and highly multiplexed on-demand molecular testing for any throughput needs. It combines advanced features, ease of use, and affordability unmatched by currently available products.
Prove-it products are rapid, DNA-based high-multiplex assays utilizing PCR and microarray technologies. Results are provided in an unambiguous and user-friendly way with Prove-it Advisor software.